| Nov 20 |
Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra
|
| Nov 18 |
The first MASH drug could open the door for others — including GLP-1s
|
| Nov 15 |
Madrigal Pharmaceuticals gains amid takeover speculation
|
| Nov 15 |
John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC
|
| Nov 14 |
Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves
|
| Nov 11 |
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
|
| Nov 10 |
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
|
| Nov 8 |
5 Small Drug Stocks to Buy as Trump Gets Re-Elected
|
| Nov 7 |
3 High Growth Tech Stocks Leading The US Market
|
| Nov 6 |
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
|
